General Information
Revision date
2015-03-02
Product name
OXALIPLATIN
CAS No.
61825-94-3
1.2.1 Relevant identified uses
Finished medicinal product
Emergency telephone
GBK/Infotrac ID 103736: (USA domestic) 1 800 535 5053 or international (001
Icons in SDS
Company Information
company name
SANDOZ Oncology Injectables
e-mail address of the competent person responsible for the Safety Data Sheet
ask.oncology@sandoz.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302, H340, H350
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
Hazard statements
T - Toxic, Xn - Harmful Harmful if swallowed. May cause genetic defects. May cause cancer. H302 Harmful if swallowed. H340 May cause genetic defects. H350 May cause cancer.
R-phrase(s)
May cause cancer. May cause heritable genetic damage. Harmful by inhalation, in contact with skin and if swallowed.
Hazard categories
Acute toxicity: Acute Tox. 4 Germ cell mutagenicity: Muta. 1A Carcinogenicity: Carc. 1A
Signal word
Danger
Hazard pictograms
GHS07-GHS08
Precautionary statements
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P270 Do not eat, drink or smoke when using this product. P281 Use personal protective equipment as required. P308+P313 IF exposed or concerned: Get medical advice/attention. P405 Store locked up.
Supplemental label elements
According to EC-rules and correspondent national legislation, this product, being a ready medicine, is not subject to mandatory identification.
2.3 Other hazards
Not known.
